128 related articles for article (PubMed ID: 12441364)
21. Polycyclic aromatic hydrocarbons stimulate human CYP3A4 promoter activity via PXR.
Luckert C; Ehlers A; Buhrke T; Seidel A; Lampen A; Hessel S
Toxicol Lett; 2013 Oct; 222(2):180-8. PubMed ID: 23845848
[TBL] [Abstract][Full Text] [Related]
22. Aryl hydrocarbon receptor-mediated and estrogenic activities of oxygenated polycyclic aromatic hydrocarbons and azaarenes originally identified in extracts of river sediments.
Machala M; Ciganek M; Bláha L; Minksová K; Vondráck J
Environ Toxicol Chem; 2001 Dec; 20(12):2736-43. PubMed ID: 11764156
[TBL] [Abstract][Full Text] [Related]
23. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
[TBL] [Abstract][Full Text] [Related]
24. EGF activates highly selective estrogen-responsive reporter plasmids by an ER-independent pathway.
Gehm BD; McAndrews JM; Jordan VC; Jameson JL
Mol Cell Endocrinol; 2000 Jan; 159(1-2):53-62. PubMed ID: 10687852
[TBL] [Abstract][Full Text] [Related]
25. Activity of benzo[a]pyrene and its hydroxylated metabolites in an estrogen receptor-alpha reporter gene assay.
Charles GD; Bartels MJ; Zacharewski TR; Gollapudi BB; Freshour NL; Carney EW
Toxicol Sci; 2000 Jun; 55(2):320-6. PubMed ID: 10828263
[TBL] [Abstract][Full Text] [Related]
26. The anti-estrogenic activity of selected polynuclear aromatic hydrocarbons in yeast expressing human estrogen receptor.
Tran DQ; Ide CF; McLachlan JA; Arnold SF
Biochem Biophys Res Commun; 1996 Dec; 229(1):101-8. PubMed ID: 8954090
[TBL] [Abstract][Full Text] [Related]
27. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
Lee AW; Nambirajan S; Moffat JG
Oncogene; 1999 Dec; 18(52):7477-94. PubMed ID: 10602507
[TBL] [Abstract][Full Text] [Related]
28. Environmental polycyclic aromatic hydrocarbons affect androgen receptor activation in vitro.
Vinggaard AM; Hnida C; Larsen JC
Toxicology; 2000 Apr; 145(2-3):173-83. PubMed ID: 10771140
[TBL] [Abstract][Full Text] [Related]
29. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells.
Foster JS; Wimalasena J
Mol Endocrinol; 1996 May; 10(5):488-98. PubMed ID: 8732680
[TBL] [Abstract][Full Text] [Related]
30. The antiestrogen ICI 182,780 inhibits proliferation of human breast cancer cells by interfering with multiple, sequential estrogen-regulated processes required for cell cycle completion.
Cicatiello L; Addeo R; Altucci L; Belsito Petrizzi V; Boccia V; Cancemi M; Germano D; Pacilio C; Salzano S; Bresciani F; Weisz A
Mol Cell Endocrinol; 2000 Jul; 165(1-2):199-209. PubMed ID: 10940498
[TBL] [Abstract][Full Text] [Related]
31. Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells.
Oh AS; Lorant LA; Holloway JN; Miller DL; Kern FG; El-Ashry D
Mol Endocrinol; 2001 Aug; 15(8):1344-59. PubMed ID: 11463858
[TBL] [Abstract][Full Text] [Related]
32. Extracellular calcium downregulates estrogen receptor alpha and increases its transcriptional activity through calcium-sensing receptor in breast cancer cells.
Journé F; Dumon JC; Kheddoumi N; Fox J; Laïos I; Leclercq G; Body JJ
Bone; 2004 Aug; 35(2):479-88. PubMed ID: 15268900
[TBL] [Abstract][Full Text] [Related]
33. Contrasting effects of prenyltransferase inhibitors on estrogen-dependent cell cycle progression and estrogen receptor-mediated transcriptional activity in MCF-7 cells.
Doisneau-Sixou SF; Cestac P; Chouini S; Carroll JS; Hamilton AD; Sebti SM; Poirot M; Balaguer P; Faye JC; Sutherland RL; Favre G
Endocrinology; 2003 Mar; 144(3):989-98. PubMed ID: 12586776
[TBL] [Abstract][Full Text] [Related]
34. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
35. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
36. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
Kim K; Thu N; Saville B; Safe S
Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
[TBL] [Abstract][Full Text] [Related]
37. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
38. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional regulation of a BMP-6 promoter by estrogen receptor alpha.
Ong DB; Colley SM; Norman MR; Kitazawa S; Tobias JH
J Bone Miner Res; 2004 Mar; 19(3):447-54. PubMed ID: 15040833
[TBL] [Abstract][Full Text] [Related]
40. 17beta-estradiol-dependent activation of signal transducer and activator of transcription-1 in human fetal osteoblasts is dependent on Src kinase activity.
Kennedy AM; Shogren KL; Zhang M; Turner RT; Spelsberg TC; Maran A
Endocrinology; 2005 Jan; 146(1):201-7. PubMed ID: 15471961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
